ISSN: 2155-9619
Journal of Nuclear Medicine & Radiation Therapy
Like us on:
Make the best use of Scientific Research and information from our 700+ peer reviewed, Open Access Journals that operates with the help of 50,000+ Editorial Board Members and esteemed reviewers and 1000+ Scientific associations in Medical, Clinical, Pharmaceutical, Engineering, Technology and Management Fields.
Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on
Medical, Pharma, Engineering, Science, Technology and Business

Giant Solitary Fibrous Tumor of Posterior Mediastinum: A Case Report

Shaoli Song1*, Panli Li1, Qiufang Liu1, Zizhou Zhao2, Daoqiang Tang3, Xiaoguang Sun1, jianjun Liu1 and Gang Huang1

1Department of Nuclear Medicine, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China

2Department of Radiology, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China

3Department of Pathology, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China

*Corresponding Author:
Shaoli Song
MD and PhD, Associate Chief Physician, Department of Nuclear Medicine
Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University. Shanghai-200127, China
Tel: 86-021-68383530

Received date: December 13, 2015, Accepted date: January 11, 2016, Published date: January 15, 2016

Citation: Song S, Li P, Liu Q, Zhao Z, Tang D, et al. (2016) Giant Solitary Fibrous Tumor of Posterior Mediastinum: A Case Report. J Nucl Med Radiat Ther 7:276. doi:10.4172/2155-9619.1000276

Copyright: © 2016 Song S, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License; which permits unrestricted use; distribution; and reproduction in any medium; provided the original author and source are credited.

Visit for more related articles at Journal of Nuclear Medicine & Radiation Therapy


A 54-year-old male was taken to a hospital after experiencing persistent back pain for a month. A spinal column MRI showed a mass in T5-T8 fanterior edge. After four months follow-up, another MRI revealed the mass had grown up to the site of T3-T9. An 18F-FDG PET/CT imaging was underwent and the imaging showed three tumors mass which all had a high uptake of 18F-FDG locating in thorax, abdomen and pelvis, respectively. The thoracoscopic biopsy histological revealed the mass was mesenchymal tumor and immunohistochemistry showed positive for CD34 and CD39, that all proved the mass is solitary fibrous tumor.


Solitary fibrous tumor; MRI; PET


Solitary fibrous tumor is an uncommon tumor which is from dendritic mesenchymal cells [1]. It is a slow-growing neoplasm and present as an asymptomatic mass, when the mass grow up, some symptoms come up corresponding. So the diagnostic rate of the solitary fibrous tumor was usually not high [2].

Case Report

A 54-year-old male was taken to a hospital after experiencing persistent back pain for a month. He had no spine movement disorder, physical activity limitation and numbness. He also had no other chest complaints, such as cough, chest tightness, shortness of breath, or hemoptysis.

His smoking history consisted of ten cigarettes per day for the past ten years. Examination of the chest revealed coarse breath sounds and had no wet and dry rales. In January 2014, a sagittal spinal column magnetic resonance imaging (MRI) showed a giant stripped solid mass extended from the anterior edge of T5 down to T8.

The T2WI image showed a higher signal intermediate, on the contrary for the T1WI (Figure 1A). The following contrast-enhanced computed tomography (CECT) had the same result. In the plain scan, lung and mediastinal windows were used to read the images (Figure 1B and 1C). For the enhanced images, from arterial to venous phase, the mass strengthened gradually (Figure 1D and 1E).

Then after four months follow-up, another MRI was performed and revealed the mass had grown up from the fanterior edge of T3 down to T9 (Figure 1F). The signal information was similar to the early one.


Figure 1: The first sagittal spinal column MRI scan of T2WI and T1WI image (A). In the chest CECT scan, the lung and mediastinal windows of plain scan images (B and C). In the chest CECT scan, the enhanced images (D and E). The second follow-up sagittal spinal column MRI scan (F).

In order to definite the property of the mass, in June 2014, a fluorine-18-fluorodeoxygulucose positron emission tomography/ computed tomography (18F-FDG PET/CT) was performed. In the view of transverse section, PET/CT fusion image confirmed that the mass showed a mildly increased FDG uptake with standardized uptake value (SUV) max of 8.8 (Figure 2A). Near to the right arteria iliaca communis saw thickening soft tissue density with rough border, measuring 4 × 3.2 × 4.9 cm, SUV max of 6.8 (Figure 2B). Beside the colon sigmoideum also had a hypermatabolic activity area with SUV max of 7.1 and size of 5 × 4.6 × 4.6 cm (Figure 3C).


Figure 2: PET/CT fusion image showed the SUV information about the mass (A). Near to the right arteria iliaca communis there was a thickening soft tissue (B). The image showed that beside the colon sigmoideum there was a soft tissue (C).

On 7 July 2014, a thoracoscopic biopsy histological was taken for the lesion in the fanterior edge of thoracic. Photomicrographs (Figure 3A, hematoxylin-eosin, original magnification 40×; Figure 3B, hematoxylin-eosin, original magnification 100×) showed uniform spindled cells revealing the mass was mesenchymal tumor. The immunohistochemistry results showed that the tumor cells were negative for SMA, VIM and S-100, positive for CD34 and CD99 (Figure 3C and 3D). The mass was proved to be solitary fibrous tumor.


Figure 3: The photomicrographs of the biopsies for the mass (A, hematoxylin-eosin, original magnification 40×; B, hematoxylineosin, original magnification 100×). The immunohistochemistry results that the mass had positive for CD34 and CD99 (C and D).


A solitary fibrous tumor is a rare form of tumor that is only occasionally cited in the literature, usually in single cases. In most solitary fibrous tumor cases, CECT may show heterogeneous density, so as the MRI signal information. Traditional imaging methods are not sensitive for the diagnosis of solitary fibrous tumors [3,4].Though solitary fibrous tumors are benign tumors, about 20% of solitary fibrous tumors have maligant potential [5]. To the case in the paper, we find three focus in the patient. MRI scan as a partial imaging of the body only find one lesion, but PET/CT as a whole body scan find other two lesions. PET/CT can provide the matabolic and the whole body information that has its unique advantages in functional diagnosis [6]. In addition, some studies show that when the tumor has the maligant potential, the mass will have a high FDG uptake [7]. So the FDG uptake degree may be one factor of the tumor’s aggressive behaviour [8].

In our case, the tumors have a moderate high FDG uptake in accordance with the maligant degree. Through appropriate biopsy get the histological and the immunohistochemistry result is the gold standard of the solitary fibrous tumor disgnostic [1-9]. Surgery is the mainstay of treatment, and recurrence and the clinical outcome is mainly related to the completeness of the surgical treatment [10,11].


This work was funded by the National Natural Science Foundation of China (grants No. 81471708), and Shanghai Jiao Tong University Medical Engineering Cross research fund (No.YG2012MS13). No other potential conflict of interest relevant to this article was reported.


Select your language of interest to view the total content in your interested language
Post your comment

Share This Article

Recommended Conferences

Article Usage

  • Total views: 7623
  • [From(publication date):
    January-2016 - Dec 07, 2016]
  • Breakdown by view type
  • HTML page views : 7604
  • PDF downloads :19

Review summary

  1. Euaristos Brassington
    Posted on Oct 24 2016 at 2:58 pm
    This is an interesting article and clearly demonstrated the heterogeneity in neuroendocrine tumours. In an era of personalized medicine, it is worthy to note modifications of treatment dependent on the results of two types of PET/CT scan. There is increasing evidence of different receptor sites on tumours that make them viable to multiple treatment types. It will be interesting to see this published with a larger database of patients.

Post your comment

captcha   Reload  Can't read the image? click here to refresh

OMICS International Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
OMICS International Conferences 2016-17
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

1-702-714-7001Extn: 9037

Business & Management Journals


1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

1-702-714-7001 Extn: 9042

© 2008-2016 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version